AZ-21666

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAZ-21666
Drug Alias NameACN-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsahi Kasei Corp
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A